Literature DB >> 15722115

Nitric oxide and neurological disorders.

Andrew J Duncan1, Simon J R Heales.   

Abstract

This article aims to give a broad overview of some of the potential targets for nitric oxide (NO) in the brain. The relevance of NO in both physiological and pathological scenarios is considerable. There is substantial evidence that neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease, involve NO in their pathogenesis. Here we describe a number of cellular components which may be affected by NO, with particular relevance to neurological diseases. As the mitochondrion (in particular the electron transport chain) would appear to be of importance when considering the deleterious effects of NO, this review has a particular emphasis on that organelle. Cellular and mitochondrial antioxidants such as glutathione and ubiquinone are also discussed. In addition, the pivotal role of the astrocyte in both neuroprotection or neurodegeneration are examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722115     DOI: 10.1016/j.mam.2004.09.004

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  43 in total

1.  Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.

Authors:  Ronan S Rogers; Moyez Dharsee; Suzanne Ackloo; Jeremy M Sivak; John G Flanagan
Journal:  Mol Cell Proteomics       Date:  2011-11-29       Impact factor: 5.911

2.  Near-infrared photoactivatable nitric oxide donors with photoacoustic readout.

Authors:  Effie Y Zhou; Hailey J Knox; Christopher J Reinhardt; Gina Partipilo; Jefferson Chan
Journal:  Methods Enzymol       Date:  2020-06-15       Impact factor: 1.600

3.  Awareness of hormesis will enhance future research in basic and applied neuroscience.

Authors:  Mark P Mattson
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

4.  Total sleep deprivation inhibits the neuronal nitric oxide synthase and cytochrome oxidase reactivities in the nodose ganglion of adult rats.

Authors:  Hung-Ming Chang; Un-In Wu; Tzer-Bin Lin; Chyn-Tair Lan; Wei-Ching Chien; Wei-Ling Huang; Jeng-Yung Shieh
Journal:  J Anat       Date:  2006-08       Impact factor: 2.610

5.  Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.

Authors:  Fengtian Xue; Jianguo Fang; William W Lewis; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2009-11-22       Impact factor: 2.823

6.  The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.

Authors:  Lauriaselle Afanador; Ina Mexhitaj; Carolyn Diaz; Dalila Ordonez; Lisa Baker; Jesus A Angulo
Journal:  Brain Res       Date:  2013-03-19       Impact factor: 3.252

7.  Increased expression and local accumulation of the prion protein, Alzheimer Aβ peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes.

Authors:  Claudine L Bitel; Yicheng Feng; Nizar Souayah; Peter H Frederikse
Journal:  BMC Physiol       Date:  2010-09-06

8.  Increased isolevuglandin-modified proteins in glaucomatous astrocytes.

Authors:  Bharathi Govindarajan; Anna Junk; Mabel Algeciras; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  Mol Vis       Date:  2009-06-01       Impact factor: 2.367

9.  Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.

Authors:  Skyla T Carney; Michael L Lloyd; Shanta E MacKinnon; Doshandra C Newton; Jenelle D Jones; Allyn C Howlett; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-14       Impact factor: 4.147

10.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

Authors:  Elsa D Garcin; Andrew S Arvai; Robin J Rosenfeld; Matt D Kroeger; Brian R Crane; Gunilla Andersson; Glen Andrews; Peter J Hamley; Philip R Mallinder; David J Nicholls; Stephen A St-Gallay; Alan C Tinker; Nigel P Gensmantel; Antonio Mete; David R Cheshire; Stephen Connolly; Dennis J Stuehr; Anders Aberg; Alan V Wallace; John A Tainer; Elizabeth D Getzoff
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.